Alterity Therapeutics Limited

DB:PBN Stock Report

Market Cap: €17.5m

Alterity Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:PBN Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
30 Jan 24Sell€46,372Regal Partners LimitedCompany16,500,000€0.003
08 Jan 24Buy€15,302Peter MarksIndividual7,142,857€0.0021

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of PBN?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders234,059,9614.4%
Private Companies320,619,2586.03%
General Public2,056,102,29438.6%
Institutions2,709,554,60550.9%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 89.9%.


Top Shareholders

Top 25 shareholders own 60.66% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
39%
BNY Asset Management
2,074,681,348€6.8m0%no data
3.45%
Regal Partners Limited
183,370,294€604.5k0%0.04%
2.35%
Merrill Lynch & Co. Inc., Banking Investments
125,280,000€413.0k0%no data
2.33%
JPMorgan Chase & Co, Brokerage and Securities Investments
123,856,611€408.3k0%no data
2.15%
Life Biosciences, Inc.
114,560,400€377.7k0%no data
1.22%
Kyriaco Barber Pty Ltd
65,000,000€214.3k0%no data
0.99%
Mst Financial Services Pty Ltd, Asset Management Arm
52,517,122€173.1k0%85.19%
0.83%
Andrew Seton
44,203,475€145.7k151%no data
0.81%
One Managed Investment Funds Limited
42,857,143€141.3k0%0.23%
0.75%
The Hartman Investment
40,000,000€131.9k0%no data
0.72%
Jagen Pty Ltd
38,556,497€127.1k0%2.0%
0.7%
Lan Au Buu
37,211,096€122.7k140%no data
0.67%
M F Cunningham Pty Ltd
35,571,429€117.3k0%no data
0.61%
Satur Investments Pty Ltd
32,271,429€106.4k0%no data
0.56%
Spiceme Capital Pty Ltd
30,000,000€98.9k0%no data
0.54%
Craig Chapman
28,571,429€94.2k0%no data
0.54%
Elif Gunes
28,571,429€94.2k58.7%no data
0.5%
Morgan Stanley, Investment Banking and Brokerage Investments
26,691,000€88.0k-8.05%no data
0.49%
Scott Nicholls
26,000,000€85.7k0%no data
0.28%
Geoffrey Kempler
14,795,000€48.8k-17.9%no data
0.28%
Kim Muller
14,677,092€48.4k0%no data
0.28%
Jeffrey Keller
14,677,092€48.4k0%no data
0.27%
HB Wealth Management, LLC
14,269,800€47.0k0%no data
0.2%
David Stamler
10,697,857€35.3k-24.9%no data
0.16%
Susquehanna International Group, LLP, Asset Management Arm
8,359,200€27.6k-40.2%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 13:42
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Alterity Therapeutics Limited is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
George ZavoicoB. Riley Securities, Inc.
Vernon BernardinoFBR Capital Markets & Co.
George ZavoicoH.C. Wainwright & Co.